BioSpace News Archive

Pharm Country

Starton Therapeutics Successfully Demonstrates Continuous Drug Delivery of Lenalidomide from a Transdermal Patch in an In Vivo Nonclinical Study with STAR-LLD

STAR-LLD is believed to be the first continuously delivered immunomodulatory imide drug (IMiD) in development to expand the use of lenalidomide in multiple myeloma and become the first IMiD for CLL.

January 24, 2022
·
4 min read
Business

Arbutus Announces 2022 Corporate Objectives and Provides Financial Update

Arbutus Biopharma Corporation today announced its 2022 corporate objectives and provided a financial update.

January 24, 2022
·
11 min read
Pharm Country

TG Therapeutics to Participate in the B. Riley Securities 2022 Virtual Oncology Investor Conference

TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that Michael S. Weiss, the Company’s Chairman and Chief Executive Officer, will participate in a fireside chat during the B. Riley Securities’ 2022 Virtual Oncology Investor Conference, taking place on Thursday, January 27, 2022, at 10:00 AM ET.

January 24, 2022
·
1 min read
Biotech Bay

Cytokinetics Announces Recipients of Fourth Annual Communications Fellowship Grants

Cytokinetics, Incorporated announced the recipients of its fourth annual Communications Fellowship Grant program, intended to support increased capacity in communications, awareness building and community engagement for nonprofit organizations serving the patient community.

January 24, 2022
·
7 min read
The Canadian Intellectual Property Office intends to grant RhoVac’s patent application for RV001 (onilcamotide) cancer vaccine

RhoVac AB (“RhoVac”) announces today, 24th January 2022, that the Canadian Intellectual Property Office (“CIPO”) has issued a " Notice of Allowance”, which means that it intends to grant RhoVac’s patent application for RV001 (onilcamotide) cancer vaccine.

January 24, 2022
·
2 min read
Business

EdiGene Enters Strategic R&D Collaboration with Haihe Laboratory of Cell Ecosystem to Develop Hematopoietic Stem Cell Regenerative Therapies and Platform Technologies

EdiGene, Inc. announced a research and development collaboration with Haihe Laboratory of Cell Ecosystem to develop hematopoietic stem cell regenerative therapies and platform technology by combining resources and expertise from both sides.

January 24, 2022
·
5 min read
Drug Development

KalVista Pharmaceuticals Announces Publication of Oral HAE Therapy KVD900 Phase 1 Data in Journal of Allergy and Clinical Immunology

KalVista Pharmaceuticals Announces Publication of Oral HAE Therapy KVD900 Phase 1 Data in Journal of Allergy and Clinical Immunology

January 24, 2022
·
4 min read
Business

Expansion Therapeutics Names Sudhir Rao Senior Vice President of Business Development

Expansion Therapeutics, Inc. today announced the appointment of Sudhir Rao, M.S., M.B.A., to the position of Senior Vice President of Business Development.

January 24, 2022
·
3 min read
SeqOne Genomics Closes €20M Series a to Accelerate the Deployment of Its Genomic Medicine Platform

SeqOne Genomics, provider of next genomic analysis solutions for personalized medicine today announced a Series A funding round of €20M.

January 24, 2022
·
4 min read
Drug Development

AIM ImmunoTech Announces Publication of Positive Results from Phase 1/2 Study of Intraperitoneal Chemo-Immunotherapy in Advanced Recurrent Ovarian Cancer

AIM ImmunoTech Inc. (NYSE: American AIM) (“AIM” or the “Company”), today announced the publication of positive data from a Phase 1/2 study of intraperitoneal chemo-immunotherapy in advanced recurrent ovarian cancer.

January 24, 2022
·
7 min read